Core Points - The supervisory board of Guangzhou Da'an Gene Co., Ltd. held its sixth meeting of the eighth session on March 27, 2025, where several key resolutions were passed [1][2][3] Group 1: Supervisory Board Resolutions - The 2024 Annual Supervisory Board Work Report was approved with a unanimous vote of 5 in favor [1] - The 2024 Annual Financial Settlement Proposal was approved, noting a significant decline in performance due to increased bad debt provisions and a decrease in the fair value of other non-current financial assets [2] - The 2024 Annual Report and its summary were approved, with the supervisory board confirming that the report accurately reflects the company's situation without any misleading statements [2][3] Group 2: Profit Distribution and Financial Management - The 2024 Profit Distribution Proposal was approved, indicating that the company will not distribute cash dividends or issue bonus shares due to negative net profits [3][5] - The 2024 Internal Control Evaluation Report was approved, confirming the effectiveness of the company's internal control system [5][6] - The proposal for expected related party transactions for 2025 was approved, with the supervisory board ensuring compliance with relevant laws and regulations [6][7] Group 3: Financial Management and Policy Changes - The proposal for using idle self-owned funds for cash management in 2025 was approved [7] - The proposal for changes in accounting policies was approved [7]

证券代码：688307 证券简称：中润光学 公告编号：2025-011 嘉兴中润光学科技股份有限公司 关于使用部分暂时闲置的募集资金及自有资金 进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 嘉兴中润光学科技股份有限公司（以下简称"公司"）于2025年3月28日分别 召开了第二届董事会第七次会议和第二届监事会第六次会议，分别审议通过了《关 于使用部分暂时闲置的募集资金及自有资金进行现金管理的议案》。根据决议， 在不影响公司募投项目正常实施进度的情况下，公司及子公司计划使用不超过人 民币3.00亿元（含本数）部分暂时闲置的募集资金及不超过人民币3.00亿元（含本 数）的自有资金进行现金管理，用于购买安全性高、流动性好、有保本约定的投 资产品（包括但不限于保本型理财产品、结构性存款、通知存款、定期存款、大 额存单等），使用期限自2024年度股东大会审议通过之日起12个月，在上述额度 内的资金可在投资期限内滚动使用，其中与募集资金相关的现金管理资金期满后 归还至公司募集资金专项账户。 在授权额度范围内，董事会 ...

证券代码：603286 证券简称：日盈电子 公告编号：2025-024 江苏日盈电子股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 现金管理额度及期限：江苏日盈电子股份有限公司（以下简称"公司"）拟 使用额度不超过人民币 18,000 万元（包含本数）的部分闲置自有资金进行现金 管理，期限为自公司本次董事会审议通过之日起至下一年度董事会召开之日止， 在上述额度内的资金可以循环滚动使用。 现金管理种类：包括但不限于银行、信托公司、证券公司、基金公司、期货 公司、保险资产管理机构、金融资产投资公司等资信状况及财务状况良好、无不 良诚信记录以及盈利能力强的合格专业理财机构发行的理财产品。 已履行的审议程序：本次现金管理事项已经公司 2025 年 3 月 27 日召开的 第五届董事会第三次会议及第五届监事会第三次会议审议通过，无需提交股东大 会审议。 特别风险提示：尽管公司拟使用部分闲置自有资金在授权额度范围内购买资 信状况及财务状况良好、无不良诚信记录以及盈利能力强的合格专业理财机构发 行的理财产品，但 ...

Group 1 - The core viewpoint of the article is the performance and operational details of Rongcheng Accounting Firm, including its audit services and financial metrics for 2023 [2][4][12] - As of December 31, 2024, Rongcheng Accounting Firm has 212 partners and 1,552 registered accountants, with 781 having signed audit reports for securities services [1] - The total audited revenue for Rongcheng Accounting Firm in 2023 was approximately 287.22 million yuan, with audit business revenue at about 274.87 million yuan and securities and futures business revenue at approximately 149.86 million yuan [2] Group 2 - Rongcheng Accounting Firm undertook the audit of 394 listed companies for their 2023 annual reports, with total audit fees amounting to approximately 48.84 million yuan [2] - The firm has a strong client base in various industries, primarily in manufacturing and information technology services [2] - The firm has purchased professional liability insurance with a cumulative compensation limit of no less than 200 million yuan [3] Group 3 - In the past three years, Rongcheng Accounting Firm has faced no criminal or administrative penalties, but has received 14 supervisory measures and 6 self-regulatory measures [5] - The firm has been involved in a civil lawsuit regarding securities false statements related to LeEco, with a judgment requiring it to share liability for losses with LeEco [4] Group 4 - The audit fees for 2024 for the company are set at 848,000 yuan, remaining stable compared to the previous period [11] - The audit committee has conducted a thorough review of Rongcheng Accounting Firm's qualifications and has recommended its reappointment for the 2025 audit [12][13] Group 5 - The company has reported a total of 38.32 million yuan raised from its initial public offering, with a net amount of approximately 33.04 million yuan after deducting issuance costs [17] - As of December 31, 2024, the company has utilized approximately 39.85 million yuan of the raised funds, with a remaining balance of about 10.23 million yuan [18] Group 6 - The company has established a fundraising management system to ensure compliance with regulations and protect investor interests [19] - The company has signed a tripartite supervision agreement for the management of raised funds, ensuring all parties fulfill their responsibilities [20]

Investment Overview - The company plans to utilize idle self-owned funds for cash management to increase investment returns, with a maximum daily balance of 700 million yuan allocated for purchasing financial products [1] - The financial products will be of medium to low risk, with a focus on high safety and liquidity, ensuring that principal-protected products have a maturity of no more than one year, while non-principal-protected products will have a maturity of less than 90 days [1] Approval Process - The investment proposal has been approved by the company's board and will be submitted for review at the 2024 annual shareholders' meeting [2] Risk Analysis and Control Measures - The company acknowledges potential market volatility risks affecting the investment but has established internal control measures to manage and mitigate these risks [2] - The company will adhere to relevant regulations and guidelines to ensure the safety of the investment funds and will take timely actions to address any adverse factors [2] Impact on the Company - The investment in financial products is expected to enhance the efficiency and returns of the company's idle funds without impacting its liquidity or operational funding needs [2] Accounting Policies - The company will follow the relevant accounting standards for financial instruments to ensure proper accounting and disclosure of the investment activities [2]

Core Viewpoint - The company intends to utilize part of its idle raised funds and idle self-owned funds for cash management, ensuring that it does not affect the normal operation of fundraising investment projects and aims to improve fund utilization efficiency and returns for shareholders [1][4][10]. Fundraising Situation - The company successfully issued 17 million shares at a price of 44.48 RMB per share, raising a total of 756.16 million RMB, with a net amount of 675.72 million RMB after deducting related issuance costs [1][2]. Fund Usage and Idle Reasons - The company has adjusted its fundraising investment projects, reallocating funds to a new project for producing 300 tons of A-40 (Atorvastatin Calcium) raw materials, with a total investment of 694.85 million RMB [2][3]. Previous Cash Management - The company approved the use of up to 100 million RMB of idle raised funds and 50 million RMB of excess raised funds for cash management, focusing on low-risk, high-liquidity financial products [3][4]. Current Cash Management Plan - The company plans to use up to 300 million RMB of idle raised funds and 300 million RMB of idle self-owned funds for cash management, with a maximum investment period of 12 months [5][6][9]. Decision Approval Process - The independent directors and the board of supervisors have reviewed and approved the cash management proposals, confirming compliance with relevant regulations and ensuring no harm to shareholder interests [8][10].

Core Viewpoint - Jiangsu Nonghua Smart Agriculture Technology Co., Ltd. held its 19th meeting of the 9th Board of Directors, where several key proposals were approved, including the 2024 annual report and various financial and operational reports, which will be submitted for shareholder approval [1][2][3]. Financial Performance - The company reported a net profit of 8,377,736.12 yuan for the parent company in 2024, while the consolidated net profit attributable to shareholders was -47,687,074.29 yuan, indicating a loss [3]. - As of the end of 2024, the parent company's undistributed profits were -100,361,075.26 yuan, and the consolidated undistributed profits were -822,583,327.82 yuan, leading to a decision not to distribute profits for the year [3]. Governance and Management - The Board approved the 2024 annual work report and the general manager's work report, both of which will be presented at the upcoming shareholder meeting [2]. - The total remuneration for non-independent directors, supervisors, and senior management for 2024 was set at 7,779,200 yuan, with the 2025 remuneration plan remaining consistent with 2024 [3][4]. Asset Management - The company approved a provision for asset impairment totaling 29,612,100 yuan for 2024, which will reduce the total profit for the year by the same amount [5]. - A comprehensive credit limit of up to 500 million yuan for 2025 was approved for applications to financial institutions, which can be used for various financing methods [6]. Shareholder Engagement - The company plans to hold its 2024 annual shareholder meeting on April 18, 2025, to discuss the approved proposals and other business matters [12]. Board Composition - The Board proposed candidates for the 10th Board of Directors, including both independent and non-independent directors, which will be subject to shareholder approval [10][11].

证券代码：688278 证券简称：特宝生物 公告编号：2025-012 厦门特宝生物工程股份有限公司 关于使用部分闲置自有资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 厦门特宝生物工程股份有限公司（以下简称"公司"）于 2025 年 3 月 27 日分 别召开第九届董事会第七次会议及第九届监事会第四次会议，审议通过了《关于使 用部分闲置自有资金进行现金管理的议案》，同意公司及子公司在确保日常经营资 金需求和风险可控的前提下，使用最高不超过人民币 6 亿元（包含本数）的暂时闲 置自有资金适时适量地进行现金管理，授权期限自本次董事会审议通过之日起 12 个月，在上述额度和期限内，资金可循环滚动使用。本事项无需提交股东大会审议， 现就该事项的具体情况公告如下： 一、现金管理基本情况 （一）现金管理目的 在额度范围及授权期限内，授权公司管理层研究决定上述现金管理具体事项， 并报总经理审批，公司财务中心负责具体实施，审计部负责监督。 （六）信息披露 在确保日常经营资金需求和风险可控的前提下，通过对部分闲置自 ...

Core Viewpoint - The company has demonstrated resilience and growth in revenue despite external economic challenges, with a reported revenue increase of 29.31% year-on-year for 2024, reaching approximately 2.03 billion yuan [5][22][23]. Financial Performance - The company achieved a total revenue of 202,734.76 thousand yuan in 2024, marking a 29.31% increase compared to the previous year [5][23]. - The net profit attributable to the parent company was 55,984.1 thousand yuan, reflecting a significant decline of 52.56% year-on-year [5][23]. - Total assets as of December 31, 2024, amounted to 235,153.61 thousand yuan, representing a growth of 32.09% [5][23]. - The net assets attributable to shareholders increased by 2.73%, totaling 130,433.08 thousand yuan [5][23]. Shareholder Meeting Proposals - The agenda for the upcoming shareholder meeting includes proposals for the confirmation of director and supervisor remuneration for 2024 and 2025, as well as the reappointment of the accounting firm for the 2025 fiscal year [2][10]. - Proposals related to the issuance of A-shares to specific targets in 2024 are also on the agenda, including feasibility studies and plans for the use of raised funds [2][10][12]. Corporate Governance - The board of directors has emphasized the importance of compliance and effective governance, with a focus on enhancing internal control systems and risk management frameworks [14][17]. - The company has maintained a commitment to transparent information disclosure, successfully completing multiple reports and announcements as required by regulatory bodies [14][21]. Future Outlook - The company aims to continue improving operational management and achieving its business objectives for 2025, with a focus on sustainable development and maximizing shareholder value [17][20].

国科军工: 关于使用部分闲自有资金进行现金管理 的公告 证券代码：688543 证券简称：国科军工 公告编号：2025-015 江西国科军工集团股份有限公司 关于使用部分闲置自有资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 （五）实施方式 （二）投资额度及期限 根据公司当前的资金使用状况并考虑保持充足的流动性，拟增加闲置自有资 金现金管理额度 30,000 万元，增加额度后的自有资金现金管理额度合计人民币 在上述最高投资额度和期限范围内，资金可以循环滚动使用。 （三）投资产品 为控制风险，公司拟使用闲置自有资金投资定期存款、大额存单、商业银行 理财产品、结构性存款和证券公司固定收益凭证等安全性高、流动性好的投资产 品。以上投资品种不涉及证券投资，不得用于股票及其衍生产品、证券投资基金 和以证券投资为目的或无担保债券为投资标的的银行理财或信托产品。 （四）决议有效期 自公司董事会审议通过之日起 12 个月内有效。 江西国科军工集团股份有限公司（以下简称"公司"）于 2025 年 3 月 24 日 召 ...